SPDR S&P Biotech ETF (XBI) Shares Sold by Banque Pictet & Cie SA

Banque Pictet & Cie SA decreased its position in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 28.7% in the 1st quarter, HoldingsChannel.com reports. The institutional investor owned 101,565 shares of the exchange traded fund’s stock after selling 40,865 shares during the period. Banque Pictet & Cie SA’s holdings in SPDR S&P Biotech ETF were worth $9,196,000 at the end of the most recent quarter.

Several other hedge funds have also recently made changes to their positions in the company. Joseph P. Lucia & Associates LLC bought a new stake in SPDR S&P Biotech ETF during the 1st quarter worth about $390,000. Trust Co. of Vermont lifted its position in SPDR S&P Biotech ETF by 135.1% during the 1st quarter. Trust Co. of Vermont now owns 5,954 shares of the exchange traded fund’s stock worth $539,000 after buying an additional 3,421 shares in the last quarter. Sigma Planning Corp lifted its position in SPDR S&P Biotech ETF by 116.8% during the 1st quarter. Sigma Planning Corp now owns 17,131 shares of the exchange traded fund’s stock worth $1,551,000 after buying an additional 9,231 shares in the last quarter. Garrison Bradford & Associates Inc. bought a new stake in SPDR S&P Biotech ETF during the 1st quarter worth about $358,000. Finally, HL Financial Services LLC lifted its position in SPDR S&P Biotech ETF by 8.1% during the 1st quarter. HL Financial Services LLC now owns 77,640 shares of the exchange traded fund’s stock worth $7,030,000 after buying an additional 5,834 shares in the last quarter.

Shares of NYSEARCA:XBI opened at $87.66 on Tuesday. SPDR S&P Biotech ETF has a one year low of $64.38 and a one year high of $101.55.

TRADEMARK VIOLATION WARNING: “SPDR S&P Biotech ETF (XBI) Shares Sold by Banque Pictet & Cie SA” was reported by The Lincolnian Online and is the property of of The Lincolnian Online. If you are reading this report on another publication, it was stolen and republished in violation of U.S. & international copyright and trademark legislation. The correct version of this report can be viewed at https://www.thelincolnianonline.com/2019/05/07/spdr-sp-biotech-etf-xbi-shares-sold-by-banque-pictet-cie-sa.html.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.

See Also: How to Use a Moving Average for Trading 

Want to see what other hedge funds are holding XBI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for SPDR S&P Biotech ETF (NYSEARCA:XBI).

Institutional Ownership by Quarter for SPDR S&P Biotech ETF (NYSEARCA:XBI)

Receive News & Ratings for SPDR S&P Biotech ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P Biotech ETF and related companies with MarketBeat.com's FREE daily email newsletter.